Show channels:
Found 15757 articles
 
Most (83.5%) participants reported being satisfied/highly satisfied with having tumour testing completed. »
04/13/22
 
 
Systemic delivery of HTL-001 resulted in improved control of subcutaneous murine and human xenograft tumours. »
04/13/22
 
 
 
 
 
Median event-free survival 31.6 months. »
04/11/22
 
 


Copyright 2026 InterMDnet | Privacy Policy | Disclaimer | System Requirements